1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Maximum Tolerated Dose: new trials by email Literature Review of Maximum Tolerated Dose trials Research Report on Maximum Tolerated Dose
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Bendamustine and IXAZOMIB (MLN9708) Plus Dexamethasone in Relapsed/Refractory Multiple Myeloma MLN9708, Dexamethasone, Bendamustine (multiple dose levels) - Multiple Myeloma | Phase 1 / Phase 2 | Completed | Parameswaran Hari | 38 | 2015-10-09 | 2020-10-22 |
Multiple Myeloma (1)
United States (1)